Pharmacy Benefit Manager
FTC Targets Pharmacy Benefit Managers Over Exorbitant Price Hikes on Specialty Generic Drugs
FTC, Pharmacy Benefit Managers, PBM, Specialty Generic Drugs, Price Hikes, Healthcare Costs
Congress Eyes Major PBM Reforms in Year-End Spending Bill
Pharmacy Benefit Managers (PBMs), PBM reforms, healthcare costs, year-end spending bill, Congress, bipartisan legislation, transparency, drug prices.
Senators Wyden and Brown Call for FTC Investigation into PBM “Co-Manufacturing” Practices
PBM reforms, FTC investigation, co-manufacturing, pharmacy benefit managers, drug costs, competition, healthcare industry
Cigna’s Express Scripts Files Lawsuit Against FTC Over Allegedly Biased PBM Report
Express Scripts, FTC, PBM Report, Lawsuit, Biased, Erroneous, Drug Prices, Healthcare
House Oversight Chair Demands PBM Executives Correct False Testimonies
PBM Executives, False Testimonies, House Oversight Chair, James Comer, Pharmacy Benefit Managers, Congressional Hearing
Biogen Faces Lawsuit Over Alleged Kickback Scheme to Block Generic Competition for Multiple Sclerosis Drug Tecfidera
Biogen, kickback scheme, Tecfidera, generics, multiple sclerosis, PBM, lawsuit
PBM Executives Avoid Tough Questions in House Committee Hearing
PBM executives, House committee hearing, pharmacy benefit managers, CVS Caremark, Express Scripts, Optum Rx
Elevance Health Surpasses Expectations in Q2 with $2.3 Billion Profit
Elevance Health, Q2 earnings, profit, revenue, Carelon, PBM, insurance premiums